Testing effectiveness (Phase 2)Study completedNCT05007509
What this trial is testing
Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19)
Who this might be right for
Covid19SARS CoV 2 Infection
Laboratorios Hipra, S.A. 30